CY1115326T1 - Φυτικη συνθεση για τη θεραπεια ή την προληψη ιογενων νοσων του αιματος, που προκαλουνται απο τον ιο της ανθρωπινης ανοσοανεπαρκειας (hiv) ή την ηπατιτιδα c - Google Patents

Φυτικη συνθεση για τη θεραπεια ή την προληψη ιογενων νοσων του αιματος, που προκαλουνται απο τον ιο της ανθρωπινης ανοσοανεπαρκειας (hiv) ή την ηπατιτιδα c

Info

Publication number
CY1115326T1
CY1115326T1 CY20141100216T CY141100216T CY1115326T1 CY 1115326 T1 CY1115326 T1 CY 1115326T1 CY 20141100216 T CY20141100216 T CY 20141100216T CY 141100216 T CY141100216 T CY 141100216T CY 1115326 T1 CY1115326 T1 CY 1115326T1
Authority
CY
Cyprus
Prior art keywords
hiv
prevention
treatment
diseases caused
virus
Prior art date
Application number
CY20141100216T
Other languages
English (en)
Inventor
Khatib Nadia El
Kettany Sleimen El
Original Assignee
Kettany Sleimen El
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kettany Sleimen El filed Critical Kettany Sleimen El
Publication of CY1115326T1 publication Critical patent/CY1115326T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η εφεύρεση αφορά μια σύνθεση με φυτική βάση για τη θεραπεία ή την πρόληψη ιογενών νόσων του αίματος όπως είναι οι ασθένειες που προκαλούνται από τον ιό της ανθρώπινης ανοσοανεπάρκειας (HIV) ή την ηπατίτιδα C. Σύμφωνα με την εφεύρεση, η σύνθεση περιλαμβάνει κυρίως άνθη θείου, ένα φυτό που περιέχει κατεχίνες και ένα παράγοντα τανίνης, καθώς και ένα φαρμακευτικώς αποδεκτό φορέα. Η εφεύρεση αφορά επίσης τη διαδικασία παρασκευής της εν λόγω σύνθεσης. Η εφεύρεση μπορεί να εφαρμοστεί στον τομέα της θεραπείας ή πρόληψης ιογενών νόσων του αίματος όπως είναι οι ασθένειες που προκαλούνται από τον ιό της ανθρώπινης ανοσοανεπάρκειας (HIV) ή την ηπατίτιδα C.
CY20141100216T 2009-04-10 2014-03-18 Φυτικη συνθεση για τη θεραπεια ή την προληψη ιογενων νοσων του αιματος, που προκαλουνται απο τον ιο της ανθρωπινης ανοσοανεπαρκειας (hiv) ή την ηπατιτιδα c CY1115326T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR2009/050678 WO2010116048A1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang telles que les maladies causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c
EP09784375.9A EP2416794B1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c

Publications (1)

Publication Number Publication Date
CY1115326T1 true CY1115326T1 (el) 2017-01-04

Family

ID=41723043

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100216T CY1115326T1 (el) 2009-04-10 2014-03-18 Φυτικη συνθεση για τη θεραπεια ή την προληψη ιογενων νοσων του αιματος, που προκαλουνται απο τον ιο της ανθρωπινης ανοσοανεπαρκειας (hiv) ή την ηπατιτιδα c

Country Status (16)

Country Link
US (1) US20120076849A1 (el)
EP (1) EP2416794B1 (el)
JP (1) JP5472445B2 (el)
CN (1) CN102458432B (el)
AU (1) AU2009344046B2 (el)
CA (1) CA2758365A1 (el)
CY (1) CY1115326T1 (el)
DK (1) DK2416794T3 (el)
ES (1) ES2452482T3 (el)
HR (1) HRP20140230T8 (el)
PL (1) PL2416794T3 (el)
PT (1) PT2416794E (el)
RS (1) RS53216B (el)
RU (1) RU2543319C2 (el)
SI (1) SI2416794T1 (el)
WO (1) WO2010116048A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2973249B1 (fr) * 2011-03-28 2014-02-07 Centre Nat Rech Scient Utilisation de l'epigallocatechine gallate comme agent antiviral contre les infections par le virus de l'hepatite c
KR101899122B1 (ko) * 2017-04-20 2018-09-21 주식회사 제넨셀 C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
AU2021268622A1 (en) * 2020-05-04 2022-11-24 Sulfagenix, Inc. Treatment of viral infections

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202932A (en) * 1878-04-30 Improvement in hog-cholera compounds
FR2296426A1 (fr) * 1975-01-03 1976-07-30 Durupt Marie Helene Elixir
US4692342A (en) * 1985-11-14 1987-09-08 Nabisco Brands, Inc. Process for honey-roasting nuts
JPH0683635B2 (ja) * 1986-03-28 1994-10-26 株式会社ロツテ 抗菌作用の増強されたかりんエキスを配合した菓子類
FR2619716B1 (fr) * 1987-08-26 1991-02-08 Letourneur Bernard Medicament et produit veterinaire pour le traitement de la sterilite
FR2622800B1 (fr) * 1987-11-05 1990-03-23 Hauser Denis Procede de preparation d'un produit de lutte contre des affections virales en particulier des affections virales cutaneo-muqueuses,compositions pharmaceutiques et medicaments obtenus a partir de ce procede
JPH02270824A (ja) * 1989-04-13 1990-11-05 Snow Brand Milk Prod Co Ltd 逆転写酵素阻害剤
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
AU6037494A (en) * 1993-02-26 1994-09-14 Ina Levi Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
CN1300623A (zh) * 1999-12-20 2001-06-27 张发平 一种中成药
US6641801B1 (en) * 2000-04-03 2003-11-04 Love Lives Gargle method to reduce the duration of common cold symptoms
US6841174B2 (en) * 2000-09-20 2005-01-11 Zeyad Technologies Llc Herbal compositions and treatment methods
JP4365106B2 (ja) * 2001-05-25 2009-11-18 エスエス製薬株式会社 医薬配合剤
GEP20032886B (en) * 2001-08-22 2003-02-25 Maka Burdiladze Plant Species for Treatment of Chronic Hepatite
KR20010099494A (ko) * 2001-10-09 2001-11-09 이영성, 권두한 큰등골짚신나물로부터 분리한 ｂ형 간염바이러스 표면항원억제물질과 그 추출방법 및 용도
WO2004002945A1 (en) * 2002-06-29 2004-01-08 Biokorea Co., Ltd (e)-1-[[(2e, 4e)-1-hexyl-2,4-octadecadienyl]oxy]-2-hydroxydiazine and a pharmaceutical composition for treating hepatitis
JP2004161623A (ja) * 2002-11-11 2004-06-10 Noevir Co Ltd 水性スティック状抗アクネ用組成物
DE202005007603U1 (de) * 2005-05-13 2005-08-04 HD Health Development GmbH Zusammensetzung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl
FR2901699A1 (fr) * 2006-06-06 2007-12-07 Christian Maret Compositions dont les proprietes sont dues a l'association d'elements synergises, leur procede de preparation et leurs utilisations en cosmetique ou hygiene

Also Published As

Publication number Publication date
AU2009344046B2 (en) 2014-10-30
PT2416794E (pt) 2014-03-17
PL2416794T3 (pl) 2014-09-30
AU2009344046A1 (en) 2011-11-10
HRP20140230T1 (hr) 2014-05-09
HRP20140230T8 (hr) 2015-12-04
RU2543319C2 (ru) 2015-02-27
ES2452482T3 (es) 2014-04-01
WO2010116048A1 (fr) 2010-10-14
JP5472445B2 (ja) 2014-04-16
EP2416794A1 (fr) 2012-02-15
RS53216B (en) 2014-08-29
CN102458432A (zh) 2012-05-16
DK2416794T3 (en) 2014-03-17
SI2416794T1 (sl) 2014-05-30
JP2012523396A (ja) 2012-10-04
CN102458432B (zh) 2015-04-22
RU2011143088A (ru) 2013-05-10
WO2010116048A8 (fr) 2011-11-10
EP2416794B1 (fr) 2013-12-25
CA2758365A1 (fr) 2010-10-14
US20120076849A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
CY1114356T1 (el) Αναστολεις του ιου της ηπατιτιδας c
CY1123152T1 (el) Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους
PH12020500396A1 (en) Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof
TR201905009T4 (tr) Polisiklik-karbamoilpiridon bileşikleri ve bunların farmasötik kullanımları.
CY1119216T1 (el) Φαρμακευτικη συνθεση για εισπνοη
DE602008006088D1 (de) Leicht anlegbares kleidungsstück
EA201390538A1 (ru) Противовирусные соединения
NZ709260A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
CL2015001304A1 (es) Compuestos derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina; composicion farmaceutica; combinacion farmaceutica; y metodo para la preparacion de compuestos.
NZ585226A (en) Inhibitors of human immunodeficiency virus replication
NZ732391A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
PL2186830T3 (pl) Interferon alfa 2b zmodyfikowany glikolem polietylenowym, jego wytwarzanie i zastosowanie
UY32715A (es) Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados
UY32720A (es) Combinaciones farmaceuticas utiles para el tratamiento del virus de la hepatitis c (vhc), usos y metodos relacionados
WO2012047267A3 (en) Polyvalent immunogen
UA118542C2 (uk) Імуногенна сполука, що включає пептид gp41 віл, зв'язаний з білком-носієм crm197
BR112014013972A2 (pt) inibidores de hcv nssa
EA201300132A1 (ru) Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич
CY1115326T1 (el) Φυτικη συνθεση για τη θεραπεια ή την προληψη ιογενων νοσων του αιματος, που προκαλουνται απο τον ιο της ανθρωπινης ανοσοανεπαρκειας (hiv) ή την ηπατιτιδα c
BR112014015582A8 (pt) compostos antivirais
EA201290504A1 (ru) Новые производные (конденсированный гетероцикл-пиперидин)-(пиперазинил)-1-алканона или (конденсированный гетероцикл-пирролидин)-(пиперазинил)-1-алканона и их применение в качестве ингибиторов р75
GB2463584A (en) Carbohydrate-lipid constructs and their use in preventing or treating viral infection
MY149148A (en) Protein-polymer conjugates